Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-29T04:50:07.552Z Has data issue: false hasContentIssue false
  • English
  • Français

Frequency of Contamination of Single-Patient-Use Nebulizers Over Time

Published online by Cambridge University Press:  10 May 2016

David J. Weber ,
Maria F. Gergen ,
Emily E. Sickbert-Bennett ,
Kathleen A. Short ,
Kendra E. Lanza-Kaduce  and
William A. Rutala
David J. Weber*
Affiliation:
Department of Hospital Epidemiology, University of North Carolina (UNC) Health Care, Chapel Hill, North Carolina Division of Infectious Diseases, UNC School of Medicine, Chapel Hill, North Carolina
Maria F. Gergen
Affiliation:
Department of Hospital Epidemiology, University of North Carolina (UNC) Health Care, Chapel Hill, North Carolina
Emily E. Sickbert-Bennett
Affiliation:
Department of Hospital Epidemiology, University of North Carolina (UNC) Health Care, Chapel Hill, North Carolina Division of Infectious Diseases, UNC School of Medicine, Chapel Hill, North Carolina
Kathleen A. Short
Affiliation:
Department of Respiratory Care, UNC Health Care, Chapel Hill, North Carolina
Kendra E. Lanza-Kaduce
Affiliation:
Director’s Office, UNC Health Care, Chapel Hill, North Carolina
William A. Rutala
Affiliation:
Department of Hospital Epidemiology, University of North Carolina (UNC) Health Care, Chapel Hill, North Carolina Division of Infectious Diseases, UNC School of Medicine, Chapel Hill, North Carolina
*
2163 Bioinformatics, CB #7030, Chapel Hill, NC 27599 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

Adult hospitalized patients with cystic fibrosis commonly receive nebulized medications. For single-patient-use nebulizers that are cleaned after each use, there is infrequent nebulizer contamination (0%–11%) with only low numbers of epidemiologically important pathogens (less than 100 colony-forming units), and this contamination is similar after 24, 48, and 72 hours of use.

Infect Control Hosp Epidemiol 2014;35(12):1553–1546

Type
Brief Report
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 12 , December 2014 , pp. 1543 - 1546
Copyright
© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. O’Sullivan, BP, Freedman, SD. Cystic fibrosis. Lancet 2009;373:1891–1904.Google Scholar
2. Cystic Fibrosis Foundation. About cystic fibrosis. http://www.cff.org/aboutCF/. Accessed 24 January 2014 .Google Scholar
3. Daniels, T, Mills, N, Whitaker, P. Nebuliser systems for drug delivery in cystic fibrosis. Cochrane Database Syst Rev 2013;4:CD007639.Google Scholar
4. Tablan, OC, Anderson, LJ, Besser, R, Bridges, C, Hajjeh, R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53(RR-3):1–36.Google ScholarPubMed
5. Saiman, L, Siegel, J, LiPuma, J, et al. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol 2014;35(S1):S1–S67.Google Scholar
6. O’Malley, CA, VandenBrandden, SL, Zheng, XT, Polito, AM, McColley, SA. Bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting. Respir Care 2007;52:258–262.Google ScholarPubMed